Aurora Cannabis (TSE:ACB) Shares Down 2.6% – Time to Sell?

Shares of Aurora Cannabis Inc. (TSE:ACB) traded down 2.6% during trading on Wednesday. The company traded as low as C$5.42 and last traded at C$5.56. 406,437 shares changed hands during trading, a decline of 1% from the average daily volume of 410,680 shares. The stock had previously closed at C$5.71.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on ACB. ATB Cormark Capital Markets cut Aurora Cannabis from an “outperform” rating to a “tender” rating and reduced their price objective for the company from C$6.50 to C$5.60 in a research report on Wednesday, August 19th. BMO Capital Markets upgraded shares of Aurora Cannabis to a “hold” rating in a research note on Wednesday, August 5th. TD reduced their price target on shares of Aurora Cannabis from C$10.00 to C$8.00 and set a “buy” rating for the company in a report on Friday, June 12th. Finally, Canaccord Genuity Group decreased their price target on shares of Aurora Cannabis from C$6.50 to C$5.00 and set a “buy” rating on the stock in a research report on Tuesday, June 30th. Two investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of C$6.20.

Aurora Cannabis Stock Down 2.6%

The firm has a 50 day moving average of C$5.05 and a 200-day moving average of C$4.69. The company has a debt-to-equity ratio of 4.30, a current ratio of 5.36 and a quick ratio of 2.48. The stock has a market capitalization of C$344.48 million, a P/E ratio of -2.87 and a beta of 0.42.

Aurora Cannabis (TSE:ACB) last announced its quarterly earnings data on Wednesday, August 5th. The company reported C($0.07) EPS for the quarter. Aurora Cannabis had a negative return on equity of 5.21% and a negative net margin of 9.53%.The firm had revenue of C$67.55 million during the quarter. On average, equities research analysts expect that Aurora Cannabis Inc. will post -0.22 earnings per share for the current fiscal year.

About Aurora Cannabis

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.